Literature DB >> 7547245

Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology.

S A Hinchliffe1, D van Velzen, H Korporaal, P L Kok, M E Boon.   

Abstract

Human papillomavirus DNA was detected in cervical specimens from 366 sexually active young women with cytomorphologically normal cervices using the polymerase chain reaction. In 93% (25/27) of initially infected women, the same viral type was not detected upon re-examination four menstrual cycles later. These results suggest that the majority of HPV infections in young women are transient.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7547245      PMCID： PMC2034061          DOI： 10.1038/bjc.1995.438

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  15 in total

Review 1.  Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.

Authors:  M H Schiffman
Journal:  J Natl Cancer Inst       Date:  1992-03-18       Impact factor: 13.506

2.  Determinants of genital human papillomavirus infection in young women.

Authors:  C Ley; H M Bauer; A Reingold; M H Schiffman; J C Chambers; C J Tashiro; M M Manos
Journal:  J Natl Cancer Inst       Date:  1991-07-17       Impact factor: 13.506

3.  Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction.

Authors:  A J van den Brule; C J Meijer; V Bakels; P Kenemans; J M Walboomers
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes.

Authors:  P J Snijders; A J van den Brule; H F Schrijnemakers; G Snow; C J Meijer; J M Walboomers
Journal:  J Gen Virol       Date:  1990-01       Impact factor: 3.891

Review 5.  Natural history of cervical infection with human papillomaviruses.

Authors:  E A Morrison
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

6.  Variability of human papillomavirus DNA testing in a longitudinal cohort of young women.

Authors:  A B Moscicki; J Palefsky; G Smith; S Siboshski; G Schoolnik
Journal:  Obstet Gynecol       Date:  1993-10       Impact factor: 7.661

Review 7.  Human papillomaviruses in the pathogenesis of anogenital cancer.

Authors:  H zur Hausen
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

8.  Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study.

Authors:  E A Morrison; G Y Ho; S H Vermund; G L Goldberg; A S Kadish; K F Kelley; R D Burk
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

9.  Changing character of cervical cancer in young women.

Authors:  P M Elliott; M H Tattersall; M Coppleson; P Russell; F Wong; A S Coates; H J Solomon; P M Bannatyne; K H Atkinson; J C Murray
Journal:  BMJ       Date:  1989-02-04

10.  Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia.

Authors:  J Cuzick; G Terry; L Ho; T Hollingworth; M Anderson
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640
View more
  11 in total

1.  S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells.

Authors:  Fengjin Qin; Yao Song; Zijian Li; Ling Zhao; Youyi Zhang; Li Geng
Journal:  Pathol Oncol Res       Date:  2009-12-03       Impact factor: 3.201

2.  Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.

Authors:  A Touzé; S de Sanjosé; P Coursaget; M R Almirall; V Palacio; C J Meijer; J Kornegay; F X Bosch
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 3.  Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.

Authors:  J P A Baak; A-J Kruse; S J Robboy; E A M Janssen; B van Diermen; I Skaland
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

4.  Associations between serum carotenoids and tocopherols and type-specific HPV persistence: the Ludwig-McGill cohort study.

Authors:  Erin M Siegel; Neal E Craft; Eliane Duarte-Franco; Luisa L Villa; Eduardo L Franco; Anna R Giuliano
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

5.  Females with paired occurrence of cancers in the UADT and genital region have a higher frequency of either Glutathione S-transferase M1/T1 null genotype.

Authors:  Sameer G Jhavar; Rajiv Sarin; Supriya Chopra; Ashwin Kotnis; Rita Mulherkar; Roger A'hern; Jai Prakash Agarwal; Shyam Kishore Shrivastava; Ketayun A Dinshaw
Journal:  J Carcinog       Date:  2005-03-24

6.  Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort.

Authors:  J M Deacon; C D Evans; R Yule; M Desai; W Binns; C Taylor; J Peto
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

7.  Seroprevalence of human papillomavirus immunoglobulin G antibodies among women presenting at the reproductive health clinic of a university teaching hospital in Nigeria.

Authors:  M Aminu; Jz Gwafan; Hi Inabo; Ao Oguntayo; Ee Ella; Ak Koledade
Journal:  Int J Womens Health       Date:  2014-05-13

8.  Validation of CINtec® PLUS Cytology Kit in the Diagnosis of Persistent HPV Infections - Cohort Study in the Portuguese Population.

Authors:  Ângela L Abreu; Regina A Silva; Sílvia Fernandes
Journal:  J Cytol       Date:  2021-05-10       Impact factor: 1.000

9.  Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Jessica S Vigliotti; Suri Pappu
Journal:  Infect Agent Cancer       Date:  2007-06-05       Impact factor: 2.965

10.  HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.

Authors:  J K Chan; B J Monk; C Brewer; K A Keefe; K Osann; S McMeekin; G S Rose; M Youssef; S P Wilczynski; F L Meyskens; M L Berman
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.